{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-005153","form_type":"8-K","ticker":"BCRX","cik":"0000882796","company_name":"BIOCRYST PHARMACEUTICALS INC","filed_at":"2021-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.060008+00:00","generated_at":"2026-06-30T01:57:25.868201+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BioCryst appoints Vincent Milano, ex-ViroPharma CEO, to Board of Directors","bullets":["Board expanded to nine directors; Milano elected effective July 26, 2021.","Milano appointed to Audit and Finance Committees; initial grant of 66,667 stock options.","Milano is CEO of Idera Pharmaceuticals and former chairman/CEO of ViroPharma (developer of Cinryze for HAE).","He will receive compensation per director policy, including annual grants of 40,000 stock options."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-005153","json":"https://secwatch.observer/filing/0001171843-21-005153.json","markdown":"https://secwatch.observer/filing/0001171843-21-005153.md","text":"https://secwatch.observer/filing/0001171843-21-005153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882796/000117184321005153/0001171843-21-005153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882796/000117184321005153/f8k_072821.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T01:57:25.868201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f7d8ac6a42","claim":"Vincent J. Milano was elected as Director at BIOCRYST PHARMACEUTICALS INC.","evidence_excerpt":"elected Vincent J. Milano to fill the vacancy created by the enlargement of the Board, effective July 26, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882796/000117184321005153/0001171843-21-005153-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}